Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene MutationsFádi Fakhouri, Véronique Frémeaux‐Bacchi, Lubka T. Roumenina et al.|Journal of the American Society of Nephrology|2010Cited by 470
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpuraMatthieu Jestin, Paul Coppo, Y. Benhamou et al.|Blood|2018Cited by 163
Cardiac troponin‐I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference CenterY. Benhamou, Lautrette Alexandre, Pierre‐Yves Boëlle et al.|Journal of Thrombosis and Haemostasis|2014Cited by 139
Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort studyFlorent Joly, Frank Bridoux, Camille Cohen et al.|Blood|2018Cited by 124
Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factorsAlice Le Clech, Fádi Fakhouri, Noémie Simon‐Tillaux et al.|Kidney International|2019Cited by 119